PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,734,844 | -23.4% | 154,330 | 0.0% | 0.10% | -19.5% |
| Q2 2023 | $6,184,003 | -1.9% | 154,330 | -0.0% | 0.12% | -7.8% |
| Q1 2023 | $6,301,064 | +14.4% | 154,400 | +8.2% | 0.13% | +8.5% |
| Q4 2022 | $5,510,033 | -27.4% | 142,710 | 0.0% | 0.12% | -32.2% |
| Q3 2022 | $7,591,000 | -8.8% | 142,710 | 0.0% | 0.17% | -4.4% |
| Q2 2022 | $8,320,000 | -23.5% | 142,710 | +0.1% | 0.18% | -6.2% |
| Q1 2022 | $10,876,000 | +26.8% | 142,505 | 0.0% | 0.19% | +38.6% |
| Q4 2021 | $8,575,000 | +22.2% | 142,505 | +13.7% | 0.14% | +12.9% |
| Q3 2021 | $7,020,000 | +0.3% | 125,350 | +8.7% | 0.12% | +0.8% |
| Q2 2021 | $6,999,000 | -6.2% | 115,335 | +8.4% | 0.12% | -11.5% |
| Q1 2021 | $7,460,000 | +17.1% | 106,440 | -0.0% | 0.14% | +14.9% |
| Q4 2020 | $6,372,000 | – | 106,490 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |